Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis
ACS Infectious Diseases · 09.01.2026 · 12 (1) · 74-90
DOI: 10.1021/acsinfecdis.5c00442 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 08.12.2025. Verfasst von Vigyasa Singh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R Ken Coit College of Pharmacy, 1703 E Mabel Street, Tucson, Arizona 85721-0207, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Adenylosuccinate Lyase, Enzyme Inhibitors, Antitubercular Agents. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Adenylosuccinate lyase (ADSL), encoded by the purB gene, is an essential enzyme in the purine biosynthesis pathway of Mycobacterium tuberculosis (Mtb), making it a promising target for antimicrobial drug development. Here, we report the expression, purification, kinetic characterization, high-throughput screening (HTS), and structural analysis of Mtb ADSL. We developed a highly sensitive and scalable bioluminescent assay using a PPDK-luciferase coupling system to quantify ADSL enzymatic activity via AMP detection. This assay enabled reliable kinetic analysis and successful pilot HTS of a small-molecule library, identifying bithionol and tetraiodothyroacetic acid (Tetrac) as inhibitors of Mtb ADSL. Inhibitory activity was confirmed using an orthogonal fluorescence polarization (FP) assay and further validated using the AMP-Glo luminescence assay. Specificity was evaluated using human ADSL (huADSL) to confirm that the compounds selectively inhibited Mtb ADSL while sparing the human enzyme. Thermal shift and gel-based protein stability assays demonstrated direct binding of bithionol and Tetrac to Mtb ADSL. Furthermore, bithionol and Tetrac displayed antibacterial activity against M. tuberculosis strains H37Ra and H37Rv, with moderate to low cytotoxicity toward human cells. Supplementation with exogenous AMP restored the growth of M. tuberculosis H37Ra inhibited by bithionol and Tetrac, confirming that both compounds act through on-target engagement of Mtb ADSL. The phagocytosis assay demonstrated that the compounds retained intracellular efficacy against M. tuberculosis. Finally, we determined the crystal structures of Mtb ADSL in two apo forms at high resolution (1.78 Å and 2.1 Å), revealing conserved tetrameric architecture with distinct active-site features that differentiate Mtb from human ADSL. Modeling suggested that both compounds bind to an allosteric site adjacent to the active site. These findings provide a framework for structure-guided development of selective ADSL inhibitors as potential antitubercular agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, R Ken Coit College of Pharmacy, 1703 E Mabel Street, Tucson, Arizona 85721-0207, United States.
- Division of Genetics, New York State Department of Health, Wadsworth Center, Albany, New York 12237, United States.
- New York Structural Biology Center, New York, New York 10027, United States.
- Department of Biomedical Sciences, University at Albany, Albany, New York 12237, United States.
- The BIO5 Institute, The University of Arizona, Tucson, Arizona 85721, United States.
- Biological Chemistry Program, Department of Chemistry and Biochemistry, College of Science & College of Medicine, The University of Arizona, Tucson, Arizona 85721, United States.
ORCID-Profile: Devi Jaganathan, Kevin P Battaile, Anil K Ojha, Hongmin Li
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- University of Arizona
- National Institute of Allergy and Infectious Diseases
- Brookhaven National Laboratory
- National Institute of General Medical Sciences
- SLAC National Accelerator Laboratory
Zitieren
APA
Singh, V., Jaganathan, D., Corro, J., Chen, K., Kumar Samrat, S., Zhang, R., Ma, M., Battaile, K. P., Li, Z., Zhang, Q. Y., Xiong, R., Ojha, A. K., & Li, H. (2026). Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis. ACS Infectious Diseases, 12(1), 74-90. https://doi.org/10.1021/acsinfecdis.5c00442
Vancouver
Singh V, Jaganathan D, Corro J, Chen K, Kumar Samrat S, Zhang R, et al. Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis. ACS Infectious Diseases. 2026;12(1):74-90. doi:10.1021/acsinfecdis.5c00442
BibTeX
@article{Singh2026,
author = {Singh, Vigyasa and Jaganathan, Devi and Corro, Jamie and Chen, Ke and Kumar Samrat, Subodh and Zhang, Ran and Ma, Mengjiao and Battaile, Kevin P and Li, Zhong and Zhang, Qing-Yu and Xiong, Rui and Ojha, Anil K and Li, Hongmin},
title = {Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {1},
pages = {74--90},
doi = {10.1021/acsinfecdis.5c00442}
}
EUVIMED